Colibacillosis in Poultry: Avian Pathogenic Escherichia coli (APEC) Infections
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Avian pathogenic Escherichia coli (APEC) is a significant cause of economic loss in poultry, characterized by a distinct set of virulence-associated genes (VAGs) including those for adhesins (e.g., type 1 fimbriae), iron acquisition (e.g., aerobactin), and protectins (e.g., LPS O antigens).
- APEC infections typically initiate with colonization of the respiratory or gastrointestinal tract, followed by systemic dissemination via the bloodstream, with pathogenesis involving mechanisms like host cell adhesion, resistance to oxidative stress, and toxin-mediated damage.
- Clinical manifestations of colibacillosis are diverse and age-dependent, including yolk sac infection in neonates, airsacculitis and colisepticemia in broilers, and salpingitis/peritonitis in laying hens, often presenting with non-specific signs like depression and respiratory distress.
- Definitive diagnosis relies on isolating and identifying E. coli from affected tissues, supplemented by molecular pathotyping for APEC-specific VAGs (e.g., iroN, iss) and antimicrobial susceptibility testing to guide treatment.
- The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) APEC strains severely compromises antimicrobial therapy, necessitating exploration of alternative strategies such as bacteriophage therapy and immunoprophylaxis.
- Integrated control measures are crucial, encompassing strict biosecurity, improved management practices, prevention of viral co-infections (e.g., H9N2 avian influenza), and a One Health approach to address zoonotic potential and food safety risks.
Etiology of Avian Pathogenic Escherichia coli
Avian pathogenic Escherichia coli (APEC) constitutes a pathotype of extraintestinal pathogenic E. coli (ExPEC) responsible for colibacillosis, one of the most economically significant bacterial diseases of poultry worldwide [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. APEC strains are characterized by a distinct repertoire of virulence-associated genes (VAGs) that distinguish them from commensal E. coli isolates [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Key VAGs include those encoding adhesins (e.g., type 1 fimbriae, P fimbriae), iron acquisition systems (e.g., aerobactin, salmochelin, the iroN gene), protectins (e.g., lipopolysaccharide O antigens, K1 capsule), and toxins (e.g., hemolysin HlyE, colicins) [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. The presence of the iroN gene, for instance, has been used as a marker for APEC detection in multidrug-resistant isolates from quail [<a href="#ref-9">9</a>]. The O78 serogroup remains among the most prevalent APEC serotypes globally [<a href="#ref-12">12</a>, <a href="#ref-13">13</a>].
Genomic characterization of APEC isolates has revealed extensive diversity and the presence of plasmids harboring multiple resistance and virulence determinants [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. Complete genome sequencing of APEC from colibacillosis cases in Georgia (USA) demonstrated considerable genomic plasticity [<a href="#ref-14">14</a>]. Comparative genomic studies have identified regions shared between APEC and other ExPEC strains, including uropathogenic E. coli, indicating potential zoonotic gene pools [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. The species tropism of certain fimbrial adhesins, such as P-like fimbriae (PLF), influences host range and zoonotic potential [<a href="#ref-16">16</a>]. Emergence of extensively drug-resistant (XDR) and multidrug-resistant (MDR) APEC strains has been documented in numerous poultry-producing regions, complicating therapeutic management [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>, <a href="#ref-20">20</a>].
Pathogenesis: Molecular and Cellular Mechanisms
APEC infection typically begins with colonization of the upper respiratory tract or the gastrointestinal epithelium, followed by translocation into the bloodstream and systemic dissemination [<a href="#ref-7">7</a>, <a href="#ref-21">21</a>, <a href="#ref-22">22</a>]. The initial adhesion is mediated by fimbrial and afimbrial adhesins, including type 1 fimbriae and the autotransporter eYadA of the type V secretion system, which promote bacterial attachment to host epithelial cells and extracellular matrix components [<a href="#ref-11">11</a>]. Direct interaction between APEC and respiratory viruses, such as H9N2 avian influenza virus, has been shown to enhance bacterial adhesion through viral neuraminidase activity, thereby predisposing poultry to secondary colibacillosis [<a href="#ref-7">7</a>].
Once internalized or translocated, APEC must withstand host oxidative stress and phagocytic killing. The quorum-sensing regulator LsrR modulates resistance to oxidative stress by interfering with sulfate assimilation, thereby enhancing bacterial survival within macrophages [<a href="#ref-23">23</a>]. Two-component systems and small regulatory RNAs (sRNAs) such as RyfA and TimR orchestrate stress resistance and virulence gene expression during infection [<a href="#ref-21">21</a>]. The toxin-antitoxin system ecnAB regulates capsular sialic acid biosynthesis, modulating capsule thickness and virulence [<a href="#ref-8">8</a>]. APEC hemolysin HlyE, delivered via outer membrane vesicles, induces mitochondria-dependent apoptosis in avian HD11 macrophages, contributing to immunosuppression [<a href="#ref-10">10</a>].
Biofilm formation is a critical virulence mechanism enabling APEC persistence on both biotic and abiotic surfaces. MDR APEC strains exhibit robust biofilm formation on various surfaces, including poultry meat contact surfaces, which contributes to cross-contamination during processing [<a href="#ref-19">19</a>, <a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. Biofilm-associated gene expression differs between planktonic and sessile states, with upregulation of curli and cellulose biosynthesis genes observed in biofilm cells [<a href="#ref-25">25</a>]. Biofilm formation on stored chicken meat is a key factor in the persistence of APEC in the food chain, directly relating to the question of "raw chicken breast bacteria" contamination and the risk posed by "undercooked chicken e coli" for human exposure (though this article focuses on poultry health) [<a href="#ref-24">24</a>].
Clinical Signs
Colibacillosis manifests in several clinical forms depending on the age of the bird, the route of infection, and the virulence of the APEC strain [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>, <a href="#ref-26">26</a>]. In broiler chickens, the most common presentations include yolk sac infection (omphalitis) in neonates, respiratory colibacillosis (airsacculitis), and systemic colibacillosis (colisepticemia) [<a href="#ref-6">6</a>, <a href="#ref-22">22</a>, <a href="#ref-27">27</a>]. Clinical signs are non-specific and include depression, ruffled feathers, reduced feed and water intake, drooping wings, and respiratory distress [<a href="#ref-1">1</a>, <a href="#ref-28">28</a>]. In laying hens, colibacillosis often presents as salpingitis and peritonitis, leading to decreased egg production [<a href="#ref-29">29</a>]. Embryonic infection can result in high mortality during incubation [<a href="#ref-22">22</a>].
The common question "does chicken have e coli or salmonella" reflects public awareness of poultry as a reservoir of bacterial pathogens. While both APEC and Salmonella spp. are found in poultry, APEC is primarily a cause of disease in the birds themselves, whereas Salmonella is more frequently linked to human foodborne illness. However, APEC strains possess zoonotic potential due to shared ExPEC virulence genes, so their presence in poultry flocks has implications beyond avian health [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-20">20</a>]. Asymptomatic carriage of fluoroquinolone-resistant APEC has been documented in broiler chickens at slaughter, highlighting the risk of "raw chicken breast bacteria" entering the food chain [<a href="#ref-20">20</a>].
Pathology
Gross pathological lesions vary by disease form. In acute colisepticemia, birds exhibit fibrinous pericarditis, perihepatitis, and airsacculitis, often described as a "polyserositis" [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>, <a href="#ref-27">27</a>]. The liver and spleen may be enlarged and congested [<a href="#ref-27">27</a>]. In yolk sac infection, unabsorbed yolk contents are caseous and discolored [<a href="#ref-22">22</a>]. Salpingitis in layers is characterized by a distended oviduct filled with fibrino-caseous exudate [<a href="#ref-29">29</a>]. Histopathological examination reveals fibrinoheterophilic inflammation, bacterial emboli in capillaries, and necrotic foci in the liver and spleen [<a href="#ref-6">6</a>]. Transcriptomic analysis of chicken liver and spleen during APEC infection has shown dynamic expression of immune-related genes, including upregulation of acute phase proteins and toll-like receptors [<a href="#ref-27">27</a>].
Diagnostics
Definitive diagnosis of colibacillosis requires isolation and identification of E. coli from affected tissues (e.g., liver, spleen, pericardium, yolk sac) in pure culture [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Conventional microbiology involves culture on MacConkey agar and subsequent biochemical confirmation. Molecular detection of APEC-specific VAGs, such as iroN, iss, and ompT, is widely used for pathotyping [<a href="#ref-6">6</a>, <a href="#ref-9">9</a>, <a href="#ref-11">11</a>]. PCR-based assays targeting these genes allow differentiation of APEC from commensal E. coli [<a href="#ref-5">5</a>]. Genomic approaches, including whole-genome sequencing and comparative genomics, provide high-resolution typing for epidemiological surveillance and antimicrobial resistance profiling [<a href="#ref-3">3</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-17">17</a>]. For field surveillance, multiplex PCR panels and commercial ELISA kits can detect APEC antigens or antibodies, though culture confirmation remains the gold standard [<a href="#ref-6">6</a>].
A typical diagnostic workflow for suspected colibacillosis is illustrated below.
graph TD
A["Clinical signs: respiratory distress, depression, mortality"] --> B["Post-mortem examination: fibrinous polyserositis, omphalitis"]
B --> C1["Collect tissues: liver, spleen, pericardium, yolk sac"]
B --> C2["Collect swabs: cloacal, tracheal"]
C1 --> D["Aerobic culture on MacConkey agar"]
D --> E["Biochemical identification: E. coli"]
E --> F1["Serotyping: O78, O2, O1"]
E --> F2["Molecular pathotyping: PCR for iroN, iss, ompT"]
E --> F3["Antimicrobial susceptibility testing: disk diffusion / broth microdilution"]
F2 --> G{"APEC virulence gene profile positive?"}
G --> H["Confirm APEC pathotype"]
F3 --> I["Guide treatment selection"]
I --> J["Implement control measures"]
H --> JTreatment
Treatment of colibacillosis relies primarily on antimicrobial therapy, but the emergence of MDR and XDR APEC strains has severely compromised the efficacy of many commonly used agents [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>, <a href="#ref-20">20</a>]. Fluoroquinolones, tetracyclines, and beta-lactams are frequently ineffective due to plasmid-mediated resistance genes [<a href="#ref-3">3</a>, <a href="#ref-18">18</a>, <a href="#ref-20">20</a>]. Extended-spectrum beta-lactamase (ESBL)-producing APEC have been reported in Egypt and other regions [<a href="#ref-3">3</a>, <a href="#ref-18">18</a>]. Antimicrobial susceptibility testing is therefore essential for rational therapy selection [<a href="#ref-4">4</a>].
Alternative therapeutic strategies are under active investigation. Bacteriophage therapy has shown promise in controlling APEC infections, with phages administered via drinking water reducing systemic infection and pathology in laying hens [<a href="#ref-13">13</a>, <a href="#ref-29">29</a>]. Phage cocktails and phage antibiotic synergism can also disrupt preformed biofilms [<a href="#ref-12">12</a>, <a href="#ref-19">19</a>, <a href="#ref-30">30</a>]. Probiotic metabolites and plant-derived compounds, such as Ilex rotunda, Cyperus rotundus herb pair extract, Myrmecodia sp. extract, and deep eutectic solvent emulsions containing Piper betle L. extract, have demonstrated antimicrobial and anti-biofilm activity against APEC [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-24">24</a>, <a href="#ref-26">26</a>, <a href="#ref-31">31</a>]. Epitope-based and peptide-based vaccines, designed with machine learning, represent a novel immunoprophylactic approach [<a href="#ref-32">32</a>, <a href="#ref-33">33</a>]. In ovo delivery of trivalent inactivated nanovaccines has shown safety and immunogenicity under commercial hatchery conditions [<a href="#ref-34">34</a>]. However, vaccine development remains challenging due to APEC serotype diversity.
Control
Control of colibacillosis requires an integrated approach combining biosecurity, management practices, and vaccination. Strict hygiene in hatcheries and poultry houses reduces early exposure to APEC [<a href="#ref-22">22</a>, <a href="#ref-34">34</a>]. Embryonic thermal manipulation has been shown to enhance splenic immunity and regulate inflammatory responses to E. coli in broilers, suggesting a potential management tool for improving disease resistance [<a href="#ref-28">28</a>]. Probiotics, such as Lactobacillus plantarum ZG-7, can improve intestinal barrier function and modulate gut microbiota to reduce APEC colonization [<a href="#ref-35">35</a>].
Biosecurity measures that prevent co-infections with respiratory viruses (e.g., H9N2 avian influenza) are critical, as viral co-infection potentiates APEC adhesion and severity [<a href="#ref-7">7</a>]. Monitoring of antimicrobial resistance patterns in APEC isolates is essential for guiding empirical therapy and detecting emerging XDR clones [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-15">15</a>, <a href="#ref-18">18</a>]. The use of APEC as a marker organism for antimicrobial resistance surveillance in poultry production systems has been proposed [<a href="#ref-15">15</a>]. Ultimately, a One Health framework that addresses APEC in the context of food safety (including risks from "raw chicken breast bacteria" and "undercooked chicken e coli") and zoonotic potential is necessary for sustainable poultry production [<a href="#ref-2">2</a>, <a href="#ref-16">16</a>].
This article provides a comprehensive overview of colibacillosis in poultry caused by APEC. For further reading on specific aspects, readers are directed to related resources on this portal: Avian Colibacillosis: Etiology, Clinical Signs, and Control of Escherichia coli Infections in Poultry, Chicken Blood Bacteria: Understanding Avian Pathogenic Escherichia coli (APEC) and Colibacillosis, and E. coli and Salmonella on Raw Chicken: Comparative Pathogenesis and Food Safety.